Novel Ligands Targeting α4β1 Integrin: Therapeutic Applications and Perspectives
Among the other members of the adhesion molecules' family, α4β1 integrin, a heterodimeric receptor, plays a crucial role in inflammatory diseases, cancer development, metastasis and stem cell mobilization or retention. In many cases, its function in pathogenesis is not yet completely understood...
Main Authors: | Monica Baiula, Santi Spampinato, Luca Gentilucci, Alessandra Tolomelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fchem.2019.00489/full |
Similar Items
-
Conjecturing about Small-Molecule Agonists and Antagonists of α4β1 Integrin: From Mechanistic Insight to Potential Therapeutic Applications
by: Tingting He, et al.
Published: (2024-01-01) -
Design of α/β-Hybrid Peptide Ligands of α4β1 Integrin Equipped with a Linkable Side Chain for Chemoselective Biofunctionalization of Microstructured Materials
by: Michele Anselmi, et al.
Published: (2021-11-01) -
Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators
by: Alessandra Tolomelli, et al.
Published: (2017-07-01) -
Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration
by: Monica Baiula, et al.
Published: (2021-01-01) -
Exogenous Integrin αIIbβ3 Inhibitors Revisited: Past, Present and Future Applications
by: Danique L. van den Kerkhof, et al.
Published: (2021-03-01)